CA1116516A - Medicament sous forme de pellets mous ou de granules - Google Patents

Medicament sous forme de pellets mous ou de granules

Info

Publication number
CA1116516A
CA1116516A CA000270236A CA270236A CA1116516A CA 1116516 A CA1116516 A CA 1116516A CA 000270236 A CA000270236 A CA 000270236A CA 270236 A CA270236 A CA 270236A CA 1116516 A CA1116516 A CA 1116516A
Authority
CA
Canada
Prior art keywords
medicament
granules
pellets
soft
pellet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000270236A
Other languages
English (en)
Inventor
John H. Bell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fisons Ltd
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB260676A external-priority patent/GB1569611A/en
Application filed by Fisons Ltd filed Critical Fisons Ltd
Priority to CA000388621A priority Critical patent/CA1144862A/fr
Application granted granted Critical
Publication of CA1116516A publication Critical patent/CA1116516A/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1688Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA000270236A 1976-01-23 1977-01-21 Medicament sous forme de pellets mous ou de granules Expired CA1116516A (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA000388621A CA1144862A (fr) 1976-01-23 1981-10-23 Composition medicamenteuse

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB260676A GB1569611A (en) 1976-01-23 1976-01-23 Pelletised or granular medicament formulation
GB260876 1976-01-23
GB2608/76 1976-01-23
GB2606/76 1976-01-23

Publications (1)

Publication Number Publication Date
CA1116516A true CA1116516A (fr) 1982-01-19

Family

ID=26237614

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000270236A Expired CA1116516A (fr) 1976-01-23 1977-01-21 Medicament sous forme de pellets mous ou de granules

Country Status (12)

Country Link
JP (1) JPS5294413A (fr)
AU (1) AU506878B2 (fr)
CA (1) CA1116516A (fr)
DK (1) DK27177A (fr)
ES (1) ES455273A1 (fr)
FI (1) FI67663C (fr)
FR (1) FR2361104A2 (fr)
IE (1) IE45260B1 (fr)
LU (1) LU76618A1 (fr)
NO (1) NO148542C (fr)
SE (1) SE442950B (fr)
ZA (1) ZA77327B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6102036A (en) * 1994-04-12 2000-08-15 Smoke-Stop Breath activated inhaler

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0072046B1 (fr) * 1981-07-24 1986-01-15 FISONS plc Médicaments pour inhalation, méthodes pour leur production et formulations pharmaceutiques les contenant

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6102036A (en) * 1994-04-12 2000-08-15 Smoke-Stop Breath activated inhaler

Also Published As

Publication number Publication date
SE7700665L (sv) 1977-07-24
AU2158977A (en) 1978-08-03
NO148542C (no) 1983-11-02
FR2361104B2 (fr) 1982-09-17
JPS5294413A (en) 1977-08-09
NO770198L (no) 1977-07-26
ZA77327B (en) 1977-12-28
FI67663C (fi) 1985-05-10
IE45260B1 (en) 1982-07-28
NO148542B (no) 1983-07-25
JPS6228124B2 (fr) 1987-06-18
IE45260L (en) 1977-07-23
FI770070A (fr) 1977-07-24
FR2361104A2 (fr) 1978-03-10
AU506878B2 (en) 1980-01-24
SE442950B (sv) 1986-02-10
LU76618A1 (fr) 1977-08-12
FI67663B (fi) 1985-01-31
DK27177A (da) 1977-07-24
ES455273A1 (es) 1978-04-01

Similar Documents

Publication Publication Date Title
US4161516A (en) Composition for treating airway disease
IE41586B1 (en) Pelletised medicament formulations
US5260306A (en) Inhalation pharmaceuticals
EP0072046B1 (fr) Médicaments pour inhalation, méthodes pour leur production et formulations pharmaceutiques les contenant
US6955824B1 (en) Inhalation composition containing lactose pellets
AU687896B2 (en) Process II
UA61051C2 (en) Powder for use in dry powder inhaler (variants), method for producing powder (variants), particles used in powder (variants), method for their manufacture and additive material
JPH09504224A (ja) プロセス▲i▼
GB2105189A (en) Inhalation drugs
RU2180563C2 (ru) Препарат для ингаляции, имеющий насыпную объемную плотность от 0,28 до 0,38 г/мл, содержащий будесонид
GB1569611A (en) Pelletised or granular medicament formulation
RU2180562C2 (ru) Препарат для ингаляции, имеющий насыпную объемную плотность 0,28 - 0,38 г/мл, содержащий тербуталина сульфат, способ его получения и его применение
CA1116516A (fr) Medicament sous forme de pellets mous ou de granules
CA1144862A (fr) Composition medicamenteuse
US5980949A (en) Formulation for inhalation
DE2535258C2 (de) Inhalierbares Medikament in Pelletform
GB1569612A (en) Disodium cromoglycate pellets or granules
IE45261B1 (en) Disodium cromoglycate pellets or granules
JPH0142950B2 (fr)
GB1569613A (en) Disodium cromoglycate in a form

Legal Events

Date Code Title Description
MKEX Expiry